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Abstract
Background: Pan-genomic studies aim, for instance, at defining the core, dispensable and unique genes within a
species. A pan-genomics study for vaccine design tries to assess the best candidates for a vaccine against a specific
pathogen. In this context, rather than studying genes predicted to be exported in a single genome, with pan-
genomics it is possible to study genes present in different strains within the same species, such as virulence
factors. The target organism of this pan-genomic work here presented is Corynebacterium pseudotuberculosis, the
etiologic agent of caseous lymphadenitis (CLA) in goat and sheep, which causes significant economic losses in
those herds around the world. Currently, only a few antigens against CLA are known as being the basis of
commercial and still ineffective vaccines. In this regard, the here presented work analyses, in silico, five C.
pseudotuberculosis genomes and gathers data to predict common exported proteins in all five genomes. These
candidates were also compared to two recent C. pseudotuberculosis in vitro exoproteome results.
Results: The complete genome of five C. pseudotuberculosis strains (1002, C231, I19, FRC41 and PAT10) were
submitted to pan-genomics analysis, yielding 306, 59 and 12 gene sets, respectively, representing the core,
dispensable and unique in silico predicted exported pan-genomes. These sets bear 150 genes classified as secreted
(SEC) and 227 as potentially surface exposed (PSE). Our findings suggest that the main C. pseudotuberculosis in vitro
exoproteome could be greater, appended by a fraction of the 35 proteins formerly predicted as making part of the
variant in vitro exoproteome. These genomes were manually curated for correct methionine initiation and
redeposited with a total of 1885 homogenized genes.
Conclusions: The in silico prediction of exported proteins has allowed to define a list of putative vaccine candidate
genes present in all five complete C. pseudotuberculosis genomes. Moreover, it has also been possible to define the
in silico predicted dispensable and unique C. pseudotuberculosis exported proteins. These results provide in silico
evidence to further guide experiments in the areas of vaccines, diagnosis and drugs. The work here presented is
the first whole C. pseudotuberculosis in silico predicted pan-exoproteome completed till today.
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Background
Reverse Vaccinology (RV) [1] analyses the genome
sequence of a pathogen, which is an expected coded
sequence for all the possible expressed genes in the
pathogen’s life cycle. All Open Reading Frames (ORF’s)
derived from the genome sequence can be evaluated
using a computer program to determine their ability as
vaccine candidates, giving special attention to exported
proteins, as these are essential in host-pathogen interac-
tions. Examples of such interactions include: (i) adher-
ence to host cells, (ii) invasion of the cell to which there
is compliance, (iii) damage to host tissues, (iv) environ-
mental stresses resistance from the defense machinery
of the cell being infected, and (v) mechanisms for sub-
version of host immune response [2-5].
Regarding exported proteins, these can distinguish
between those that are exported to the cell wall, and after
cleaved, release the mature portion into the extracellular
milieu, which are referred to as secreted proteins (SEC),
and those proteins exported to the cell wall which, even
after cleaved, do not release the mature portion to the
extracellular milieu, due to one or more hydrophobic
motifs causing anchoring to the cell wall, and which are
referred to as potentially surface exposed proteins (PSE).
Different PSE subcategories exist according to the pre-
sence of a carboxy (C) or amino (N) terminal portion
anchored to the cell wall, lipoproteins (E), end terminal
loops (L), retention signals-like such as LGxTG, LysM,
GW, Choline binding and PG binding (R), in combination
or not with other PSE subcategories [6].
The term ‘Reverse’ from RV can be explained by the
reverse genetics (RG) technique. Before the dawn of
genomic, there were attempts to discover the responsible
genes from a phenotype, reversing the research path of
Crick’s Central Dogma [7] (DNA ® RNA ® Protein)
discovery. Holding the likely gene sequence, several tech-
niques can be used to identify gene sequence modifica-
tions responsible for changes in the organism’s
phenotype. Crick’s Central Dogma principle is also used
for RV, as this technique searches within a gene sequence
for possible proteins that could act as antigens capable of
stimulating an immune response in a host organism [8].
The concept of RV was adapted to fit a new reality of
widespread availability of genomic data [9]. With this
technique, instead of searching for targets in a single
strain or subspecies of an organism, it is now possible to
simultaneously research in dozen of genomes, exploring
potential joint antigens or exclusive ones to multiple gen-
omes [10]. The availability of a large number of genomes
to implement RV has lead to the emergence of the pan-
genomics reverse vaccinology concept [11], which can
also apply to the concepts of core, extended (dispensable)
and character (unique) genomes. While the core genome
is composed of exported genes (genes that transcribe for
exported proteins) that are common to these multiple
strains and could represent candidates for a vaccine, the
dispensable genome consists of genes that are absent in
at least one of the strains of the studied species and the
unique genome consists of genes that are specific to only
a particular a strain [10]. From the standpoint of vac-
cines, the core genome represents to be a good candidate
to compose a vaccine that is suitable for all studied
strains. In this regard, the first step to enable any pan-
genomic reverse vaccinology study is to predict the core
genome, along this work denominated in silico predicted
pan-exoproteome (ISPPE). The model organism here
analyzed (C. pseudotuberculosis) is a Gram-positive
(GRAM+) bacterium, intracellular facultative parasite
that affects small ruminants causing a chronic infectious
pyogranulomatous disease characterized by the formation
of abscesses in lymph nodes [12]. This pathogen infects
mainly goats and sheep causing caseous lymphadenitis,
but can also infect a huge variety of hosts throughout the
world such as camels, horses, cattle, buffaloes, llamas,
alpacas and, more rarely, humans [13-18], causing differ-
ent diseases with different degrees of severity in each of
them [12,19].
Results and discussion
In silico exoproteome prediction schema
As shown in our proposed prediction schema (Figure 1),
the software SurfG+ (Surface Gram positive), specially
configured for GRAM+ bacteria, is responsible for most
of the sub-cellular classifications, which vary between
cytoplasmic (CYT), membrane (MEM), SEC and PSE
(Figure 2). SurfG+ was configured for GRAM+ bacteria.
Figure 1 represents the prediction schema using SurfG+
and three additional software, TatP 1.0 [20], SecretomeP
2.0 [21] and NclassG+ [22], which are specialized in non-
classical secretion prediction. SurfG+ incorporates
SignalP 3.0 predictor, responsible for identification of
classical putative secreted proteins or exported proteins
by the SEC pathway [23].
The results obtained after running SurfG+, TapP,
SecretomeP and NClassG+ have gave rise to two gene
data sets labeled as SEC and PSE, which correspond to
the C. pseudotuberculosis ISPPE. These ISPPE data sets
are composed of putative proteins present fivefold (5x),
fourfold (4x), threefold (3x), twofold (2x) or onefold (1x),
where fivefold means that a gene was predicted in all five
strains, four fold meaning that a gene was predicted in
four strains, and so on. A gene fold was obtained by reci-
procal blast results, as described in the methods section.
Since not all predicted genes are named, it was necessary
to create a pan genome identifier, here denominated pan
locus, to nominate each unique gene fold. The pan locus is
unique within a pan genome and is shared by all homolo-
gous genes. For example, when a putative exported protein
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was found within the five strains, each gene copy received
the same pan locus to facilitate further data processing
and identification. Following, it was necessary to confirm
these results by systematical manual curation of each gene
using the ACT tool from the Artemis software package
[24]. Once completed this manual curation, it was possible
to answer several questions regarding the correctness of
each blast result and, as a consequence, it was possible to
identify, for instance, that a gene formerly classified as 1x
was indeed a 5x, as the other four gene copies were
created starting beyond the signal peptide motif. After
initial methionine correction, and also taking into account
homologous genes, a new prediction step indicated all
remaining putative proteins to be exported, composing the
core ISPPE. However, gene’s start positions incorporating
a less probable signal peptide motif were also observed. In
general, genes formerly predicted as Nx proved to be cor-
rect by manual curation as the remaining (5-N)x genes
were predicted as cytoplasmic, PSE or pseudogenes. These
results are particularly interesting because they compose
Figure 1 C. pseudotuberculosis pan genomic prediction schema. Software used, identified sub-cellular compartments and flow scheme to
create the final pan genomic data sets.
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the dispensable and unique ISPPE data sets. These gen-
ome annotation corrections, as a consequence of these
analyses, were incorporated into the official annotation of
the five C. pseudotuberculosis strains deposited at Gen-
Bank in August, 2011. This genomes are also available in
the additional file 1, as EMBL files.
Classical and non-classical secreted putative proteins
Figure 3 exhibits the in silico predicted pan secretome
results for C. pseudotuberculosis, which comprise 150
genes, out of 377 from the whole ISPPE, representing 750
locus_tags in the five studied C. pseudotuberculosis strains.
However, despite representing 750 locus_tags, not all were
predicted as secreted. If at least one gene copy, within a
specific pan locus, was not predicted as secreted, it still
received the same pan locus but was not classified as part
of the predicted core secretome. There are 122 genes com-
posing the predicted core secretome (5x), followed by 25
genes constituting the predicted dispensable secretome
(4x, 3x and 2x) and just 3 genes as the predicted unique
secretome (1x). These results were obtained applying the
prediction schema from Figure 1; however, different con-
tributions were obtained from different predictors, as
shown in Figure 4.
Figure 2 Predicted gene quantities by sub-cellular compartment from full C. pseudotuberculosis genomes. Classification of more than
10,000 distinct genes from the five different C. pseudotuberculosis strains in the four sub-cellular categories: cytoplasmic (CYT), membrane (MEM),
potentially surface exposed (PSE) and secreted (SEC). Predictions were made using the schema presented in Figure 1.
Figure 3 Predicted C. pseudotuberculosis pan secretome. Predictions for 150 genes from strains 1002, C231, I19, FRC41 and PAT10 made by
SurfG+ 1.0, TatP 1.0 Server and SecretomeP 2.0 Server.
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SurfG+ predicted 104 genes, corresponding 85, 18 and 1
to the predicted core, dispensable and unique secretome
respectively. On the other hand, TatP predicted 25 genes,
of which 17, 7 and 1 corresponded to the predicted core,
dispensable and unique secretome respectively. Finally,
SecretomeP and NClassG+ predicted 21 genes, corre-
sponding 20 and 1 to the predicted core and unique secre-
tome respectively. It can be easily observed that the main
predicted portion is originated by SurfG+, as it predicts
putative proteins possibly secreted by the SEC pathway. A
considerable portion of genes (~31%), only within the pre-
dicted core secretome, comes from non-classical secretion
predictors that cannot be ignored when the subject is
about vaccine candidates.
The dispensable and unique C. pseudotuberculosis pre-
dicted secretomes contain ~8%, or 58 locus_tags, not pre-
dicted as secreted. Putative proteins predicted as CYT,
PSE and putative frame shifts (pseudogenes) account for
22, 24 and 10 locus_tags respectively. In the dispensable
and unique C. pseudotuberculosis in silico predicted secre-
tomes, the numbers of genes identified as membrane inte-
gral or absent in a genome are insignificant. Nevertheless,
the manual curation step ensured no annotation errors in
these predictions, making it possible to claim the hypoth-
esis that these differences could be due to environment
adaptations. A table containing the complete list of
C. pseudotuberculosis secreted proteins is available in the
additional file 2.
Potentially surface exposed (PSE) putative proteins
The SurfG+ software was calibrated by the cell wall thick-
ness for each C. pseudotuberculosis strain. Figure 5 shows
184 genes, out of 377 from the whole ISPPE, comprising
the predicted core surfaceome (5x), 34 genes composing
the predicted dispensable surfaceome (4x, 3x and 2x) and
just 9 genes as predicted unique surfaceome (1x). These
227 genes account for 1135 locus_tags in all five strains. In
this set, homologous genes within a pan locus do not ever
share the same sub-cellular prediction. Genes predicted as
MEM, CYT, SEC and putative pseudogenes account for
29, 23, 20 and 17 distinct locus_tags, respectively. Genes
predicted as MEM (~3%) compose the second major
group. This could be explained by the fact that membrane
proteins already contain hydrophobic extension and could
be more susceptible to expose or occult parts of a protein
to the extracellular milieu. However, the same reasoning
does not suit to explain the third major group of locus_-
tags with surfaceome pan locus that correspond to pro-
teins predicted as secreted ones. These 20 locus_tags that
were predicted as secreted, but also received surfaceome
pan locus, raise a question; do these fit SEC or PSE labels?
There exist no simple paths to estimate their sub-cellular
compartment by software, since some locus_tags were pre-
dicted as PSE receiving surfaceome pan locus and other
were predicted as SEC and also received secretome pan
locus. Ten pan locus (plcppse193, plcppse194, plcppse205,
plcppse218, plcppse226, plcpsec096, plcpsec097,
plcpsec098, plcpsec100, plcpsec101) faces this question, as
some genes appear in both the predicted secretome and
surfaceome.
The PSE subcategories show predominance of genes,
as presented in Figure 6. Most of the 1045 genes pre-
dicted as PSE are cell wall anchored outward C-terminal
(~40%) (≥ 50 AA long), followed by lipoproteins
(~24%), outward loops (~11%) (≥ 100 AA long) and
outward N-terminal (~17%) (≥ 50 AA long), whereas
genes containing retention signals (PSE R) account only
for ~8%.
The PSE results of all strains were analyzed considering
that a significant cell wall thickness difference between
strain I19 and the other ones was observed (~34 nm ver-
sus ~24 nm). Despite the significant cell wall thickness
difference, a small difference was predicted in the gen-
ome, which accounts for a decrease in the number of
PSE and an increase in the number of MEM genes in
C. pseudotuberculosis strain I19. A table containing the
complete list of C. pseudotuberculosis PSE proteins is
available in the additional file 3.
Figure 4 Predicted C. pseudotuberculosis pan secretome by predictor software. Predicted secreted genes coverage in the predicted pan
secretome of the five bacterial strains separated by predictor software SurfG+, TatP and SecretomeP.
Santos et al. BMC Genomics 2012, 13(Suppl 5):S6
http://www.biomedcentral.com/1471-2164/13/S5/S6
Page 5 of 12
Revised in vitro exoproteome results
The 104 observed genes in both TPP/LC-MSE [25] and 2-
DE-MALDI-TOF/TOF, (Silva WM, Seyffert N, Castro
TLP, Santos AV, Pacheco LGC, Santos AR, Ciprandi A,
Zurita-Turk M, Dorella FA, Andrade HM, Pimenta AMC,
Silva A, Miyoshi A, Azevedo V, unpublished observations)
experiments were compared with the ISPPE results here
presented. This comparison, explained in the methods sec-
tion, brought novel insights into the in vitro exoproteome
and showed the possibility of having additional genes in
the main C. pseudotuberculosis in vitro exoproteome.
In Table 1 are listed all 35 proteins of the variant in vitro
exoproteome (strains 1002 and C231), that correspond to
~23% of the total amount. These proteins were found to
be highly conserved in the five compared C. pseudotuber-
culosis strains and comprise the core ISPPE. Moreover, it
was verified that three proteins (ADL20466, ADL20097 e
ADL19973), previously classified as belonging to the var-
iant in vitro exoproteome of strains 1002 [25], did actually
belong to the main in vitro exoproteome. These findings
Figure 5 Predicted C. pseudotuberculosis pan surfaceome. Pan surfaceome predictions for 227 genes from strains 1002, C231, I19, FRC41 and
PAT10, performed by SurfG+ 1.0.
Figure 6 Predicted C. pseudotuberculosis pan surfaceome by PSE subcategories. PSE categories are distributed in outward C-terminal or N-
terminal portion greater than or equal 50 AA. Outward N or C terminal greater than 100 AA are classified as L. Lipogenes identified by LipoP are
classified as E and retention signals identified by HMMSEARCH profiles are classified as R. These labels can also be conjugated to create other
PSE subcategories.
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give raise to the possibility that more proteins of the var-
iant in vitro exoproteome indeed make part of the main in
vitro exoproteome.
This comparison also served as a rebuttal argument
against some specific genes. The Cp1002_0369 gene,
classified under the plcpsec100 pan locus as a pseudo-
gene, was identified by the in vitro exoproteome
experiment. Interestingly, this gene copy also suits the
plcppse226 pan locus. Both pan locus make part of pre-
vious related genes that already showed difficulties to
be classified, by software, into any potential sub-cellu-
lar compartment, as some genes within the pan locus
fit both SEC and PSE labels. The in silico predictions
enforces that there are at least three secreted proteins,
inspite of the other two gene copies being predicted as
having PSE and CYT labels.









ADL19972 Cp1002_0064 Hypothetical protein PSE E CP001809
ADL20140 Cp1002_0237 slpA Surface layer protein A SEC CP001809
ADL20222 Cp1002_0320 Hypothetical protein PSE N CP001809
ADL20288 Cp1002_0388 L,D-transpeptidase catalytic domain, region YkuD SEC CP001809
ADL20391 Cp1002_0497 malE Maltose/maltodextrin transport system substrate-
binding protein
PSE E CP001809
ADL20455 Cp1002_0562 sprT Trypsin PSE C CP001809
ADL20477 Cp1002_0584 cynT Carbonic anhydrase PSE E CP001809
ADL20508 Cp1002_0615 Hypothetical protein SEC CP001809
ADL20574 Cp1002_0681 rpfB Resuscitation-promoting factor RpfB SEC CP001809
ADL20656 Cp1002_0766 Hypothetical protein SEC CP001809
ADL21028 Cp1002_1144 yceG Amino deoxychorismate lyase SEC CP001809
ADL21239 Cp1002_1362 Hypothetical protein PSE E CP001809
ADL21302 Cp1002_1425 ctaC Cytochrome c oxidase subunit II PSE C CP001809
ADL21537 Cp1002_1669 Hypothetical protein SEC CP001809
ADL21667 Cp1002_1802 lipY Secretory lipase SEC CP001809
ADL09524 CpC231_0025 pld Phospholipase D SEC CP001829
ADL09532 CpC231_0033 pbpA Penicillin-binding protein A SEC CP001829
ADL09691 CpC231_0196 Hypothetical protein SEC CP001829
ADL09697 CpC231_0203 pbpB Penicillin binding protein transpeptidase SEC CP001829
ADL09852 CpC231_0360 oppA1 Oligopeptide-binding protein oppA PSE E CP001829
ADL09871 CpC231_0379 Hypothetical protein SEC CP001829
ADL09872 CpC231_0380 malE Maltotriose-binding protein PSE E CP001829
ADL09990 CpC231_0503 lytR Transcriptional regulator lytR PSE C CP001829
ADL10248 CpC231_0766 Hypothetical protein SEC CP001829
ADL10460 CpC231_0982 ciuA Iron ABC transporter substrate-binding PSE E CP001829
ADL10489 CpC231_1012 yceI Protein yceI SEC CP001829
ADL10626 CpC231_1150 Zinc metallopeptidase PSE C CP001829
ADL10663 CpC231_1187 Lipoprotein PSE E CP001829
ADL10880 CpC231_1409 pknL Serine/threonine protein kinase PSE N CP001829
ADL11196 CpC231_1737 Corynomycolyl transferase SEC CP001829
ADL11213 CpC231_1756 Hypothetical protein SEC CP001829
ADL11326 CpC231_1871 Hypothetical protein PSE N CP001829
ADL11338 CpC231_1885 Membrane protein SEC CP001829
ADL11339 CpC231_1886 Hypothetical protein SEC CP001829
ADL11410 CpC231_1959 glpQ Glycerophosphoryl diester phosphodiesterase PSE E CP001829
The 35 proteins listed in this table were not found in the experimental main in vitro exoproteome [47; 48] but were found in the in silico predicted pan-
exoproteome of all five C. pseudotuberculosis strains.
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Furthermore, the genes plcppse180, plcppse192,
plcpsec077, plcpsec095 and plcpsec099 also had both
genes found in the main in vitro exoproteome of
strains 1002 and C231, but were not classified in the
ISPPE. The plcppse180 pan locus holds a putative
pseudogene (CpPAT10_0459), and is therefore not pre-
sent in the in silico predicted core surfaceome. Other
genes were predicted as cytoplasmic. It is possible that
these genes were wrongly assembled since there is evi-
dence that at least two homologous genes, from strains
1002 and C231, are exported to the extracellular
milieu.
Core C. pseudotuberculosis ISPPE candidates homologous
to Mtb
Within the core C. pseudotuberculosis ISPPE, homolo-
gous genes to those of the previously studied Mycobac-
terium tuberculosis H37Rv (Mtb) were observed. In this
work we present some of these homologous genes fea-
turing at least 90% protein alignment and 50% identity
within this alignment. These cut-offs were obtained dur-
ing the search for C. pseudotuberculosis homologous
genes in the Mtb genome.
The core C. pseudotuberculosis ISPPE, that accounts for
~81% of the total, is composed of 306 genes or 1,530 dis-
tinct locus_tags, being ~40% predicted as SEC and ~60%
predicted as PSE proteins, of which 20 genes present high
similarity to Mtb’s genes (Table 2); however, not all of
these Mtb genes have known functions.
In this regard, here we only discuss some of these
Mtb’s genes with experimental evidence. The plcppse174
pan locus shows 51% protein identity with Rv3915
(YP_178027.1), a gene named cwlM that was the first
autolysin gene identified and cloned from Mtb. This
finding offers a new drug target class that could alter
the permeability of the mycobacterium cell wall and
enhance the effectiveness of treatments for tuberculosis
[26]. Applying principles of in vivo expression technol-
ogy (IVET), it was possible to identify upregulated genes
fromMtb in an in vitro simulation of anaerobic persistence
condition. The upregulated genes under hypoxic condition
(dissolved oxygen <1%) include Rv0050 (ponA1), a penicil-
lin binding protein that has 52% protein identity to the
plcppse165 pan locus and 90% alignment extension [27].
The plcpsec122 pan locus shows ~58% protein identity
with Rv2752c (NP_217268.1), a unique bi-functional Mtb
gene that owns both b-lactamase and RNase activities.
Both activities are lost upon deletion of the 100 AA long
C-terminal 100 tail, which contains an additional loop
when compared to the RNase J of Bacillus subtilis [28]. As
it can be observed, the plcppse080 pan locus appears twice
in Table 2, as it is homologous to both NADH dehydro-
genase gene copies of Mtb, ndh (NP_216370.1) and ndhA
(NP_214906.1), with ~57% protein identity. In Mtb, energy
generation is mainly performed by type II dehydrogenases
ndh and ndhA, being both, as such, essential genes [29].
The plcpsec113 pan locus is homologous to the glmU
gene (NP_215534.1), holding ~59% protein identity and
more than 90% alignment extension. This gene is essential
in Mtb, being required for optimal bacterial growth, and
has been selected as a possible drug target for structural
and functional investigation [30]. GlmU is a bifunctional
acetyltransferase/uridyltransferase that catalyses the for-
mation of UDP-GlcNAc from GlcN-1-P. UDP-GlcNAc is
the substrate for two important biosynthetic pathways:
lipopolysaccharide and peptidoglycan synthesis. Due to its
important roles, glmU had its conformational structure
solved [30]. The plcpsec113 pan locus for C. pseudotuber-
culosis is an interesting putative drug candidate since it is
predicted to be secreted, part of the core ISPPE and is able
to infer its conformational structure by homology model-
ing using Mtb glmU.
Several genes involved in mannoglycoconjugate bio-
synthesis have shown to be involved in virulence, due to
their central role in biosynthesis of major surface-asso-
ciated glycoconjugates. Within these genes, the Mtb gene
manB (Rv3264c) is defined as a GDP-mannose pyropho-
sphorylase (GDPMP) and disruption of its activity leads to
decrease of surface-associated mannosylated lipoglycans.
For GDPMP, this decrease correspond directly to reduced
virulence in both BALB/c mice and cultured human
macrophages [31]. The Mtb manB gene holds 69% protein
identity to the plcpsec110 pan locus and more than 90%
alignment extension, making plcpsec110 a considerable
putative drug target.
Mycolic acids and multimethyl-branched fatty acids are
found uniquely in the cell envelope and are essential for
survival, virulence and antibiotic resistance of Mtb. Acyl-
CoA carboxylases (ACCases) commit acyl-CoAs to the
biosynthesis of these unique fatty acids. Previous studies
indicate that AccD5 is important for cell envelope lipid
biosynthesis and its disruption leads to pathogen death
[32]. The Mtb gene accD5 (NP_217797.1) had its structure
determined and also shows ~74% protein identity to the
plcppse045 pan locus in more than 90% alignment exten-
sion, making it also a promising candidate for further vac-
cine candidate evaluations.
Moreover, it was demonstrated that Mtb can use heme
as an iron source, suggesting that Mtb contains a yet-
unknown heme acquisition system [33]. We found that the
C. pseudotuberculosis plcpsec076 pan locus holds ~52%
protein identity to the Mtb gene hemE (NP_217194.1) and
more than 90% alignment size, therefore also representing
an interesting drug target for C. pseudotuberculosis.
Candidates filtering
The here presented results provide a plethora of puta-
tive vaccine candidates never seen before for
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C. pseudotuberculosis. However, genes predicted as
MEM and CYT account respectively for 18% and 65% of
the in silico predicted pan genome. Despite the 227 surfa-
ceome and 150 secretome genes here presented, these
only represents ~16% of the C. pseudotuberculosis in silico
predicted pan genome. Most of the genes remain inacces-
sible for the current in silico prediction techniques and it
is possible that these neglected genes could also be good
candidates against C. pseudotuberculosis. These findings
raise the need for more elaborated and driven software or
prediction schemas capable of uncovering these major
genome neglected portions. Using the prediction schema
here presented, it was possible to include more than ~2%
of non-classic secreted putative proteins that compose
putative vaccine candidates. However, this low income
amount of vaccine candidates is due to the optional para-
meter selected in our prediction schema, the non-classic
secreted score greater than or equal 0.90. If using the
default parameter from the software secretomeP and
NClassG+, this income would be increased up to ~6% and
the final income of putative vaccine candidates would be
~20%, using a couple of motifs predictors as depicted in
Figure 1. The current reverse vaccinology software allows
obtaining a number of candidates closer to 20% of the
C. pseudotuberculosis genome. These considerations raise
a question: supposing that novel software for unexplored
secretion pathways come into scenario, what is the gen-
ome’s percentage that could be selected as putative vac-
cine candidates? Supposing that this percentage reaches
40%, how could the problem of choosing between almost
one thousand putative vaccine candidates to be used for
the next vaccine production stage for C. pseudotuberculo-
sis be solved? This dilemma could be solved by using
further software prediction just like those addressing epi-
topes MHC class I and II allele affinity [34]; however, this
could be just a part of the solution. There are chances of
solving this dilemma by means of broader vaccine projects,
which would take into account particular variables for

















protein ID Annotated product
plcpsec106 cpfrc_00104 488 69.10 461 Rv3790 NP_218307.1 oxidoreductase
plcpsec076 cpfrc_00276 371 51.56 357 Rv2678c hemE NP_217194.1 uroporphyrinogen decarboxylase
plcppse023 cpfrc_00283 535 52.51 529 Rv0528 NP_215042.1 transmembrane protein
plcppse045 cpfrc_00491 543 73.72 548 Rv3280 accD5 NP_217797.1 propionyl-CoA carboxylase beta chain
plcpsec110 cpfrc_00506 362 69.03 359 Rv3264c manB YP_177951.1 D-alpha-D-mannose-1-phosphate
guanylyltransferase MANB
plcpsec111 cpfrc_00508 151 51.45 139 Rv3259 NP_217776.1 hypothetical protein
plcpsec113 cpfrc_00705 487 58.67 495 Rv1018c glmU NP_215534.1 bifunctional N-acetylglucosamine-1-phosphate
uridyltransferase/glucosamine-1-phosphate
acetyltransferase
plcpsec115 cpfrc_00945 64 63.33 64 Rv1642 rpmI NP_216158.1 50S ribosomal protein L35
plcppse080 cpfrc_01015 452 57.08 470 Rv0392c ndhA NP_214906.1 membrane NADH dehydrogenase
plcppse080 cpfrc_01015 452 58.10 463 Rv1854c ndh NP_216370.1 NADH dehydrogenase
plcpsec041 cpfrc_01074 403 62.96 381 Rv1488 NP_216004.1 hypothetical protein
plcpsec119 cpfrc_01121 504 53.71 457 Rv1407 fmu NP_215923.1 Fmu protein (SUN protein)
plcppse085 cpfrc_01126 417 55.58 418 Rv1391 dfp NP_215907.1 bifunctional phosphopantothenoylcysteine
decarboxylase/phosphopantothenate synthase
plcpsec138 cpfrc_01214 79 68.42 82 Rv2708c NP_217224.1 hypothetical protein
plcpsec122 cpfrc_01267 683 57.76 558 Rv2752c NP_217268.1 hypothetical protein
plcpsec124 cpfrc_01393 239 57.83 250 Rv2149c yfiH NP_216665.1 hypothetical protein
plcppse104 cpfrc_01424 412 50.38 429 Rv2195 qcrA NP_216711.1 Rieske iron-sulfur protein QcrA
plcpsec128 cpfrc_01757 313 59.42 322 Rv3579c NP_218096.1 tRNA/rRNA methyltransferase
plcppse131 cpfrc_01798 480 62.21 491 Rv2443 dctA NP_216959.1 C4-dicarboxylate-transport transmembrane protein
DctA
plcppse165 cpfrc_02038 721 52.00 678 Rv0050 ponA1 YP_177687.1 bifunctional penicillin-binding protein 1A/1B
plcppse174 cpfrc_02102 393 51.41 406 Rv3915 cwlM YP_178027.1 hydrolase
Related C. pseudotuberculosis’s proteins containing at least 50% amino acid identity and 90% alignment size to the Mtb H37Rv’s proteins.
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each target organism in order to minimise research efforts
and the number of possible vaccine candidates [35].
In silico versus non-in silico
It is broadly known that in silico genome investigations
could give evidence about the genome’s function and
structure. It is also known that such in silico investigations
could only be proved or denied by non-in silico experi-
ments. Therefore, such reasonable thinking is not a single-
hand avenue. Non-in silico experiments could be improved
by means of more comprehensive or specific approaches
with the objective of getting a closer answer to the reality
for biological questions. The fact is that in silico analyses
cannot vary when executed over and over again and no
matter how many folds are run. We know that exactly 122
genes will be always predicted as having classical exporta-
tion motifs; on the other hand, we cannot expect the same
behavior from non-in silico analysis. Some real proteins
could be or not be found in an in vitro or in vivo exopro-
teome result, due to an uncountable number of factors
[21]. Therefore, we suggest that the core C. pseudotubercu-
losis ISPPE could be composed of a larger number of pre-
dicted genes, but such confirmation could only be affirmed
with additional non-in silico exoproteome experiments.
Conclusions
The in silico pan-exoproteome prediction methodology
applied to the pathogen C. pseudotuberculosis helps to
raise new insights into putative vaccine candidates
against CLA. Additional investigations of the in vitro
exoproteome of two strains of C. pseudotuberculosis,
1002 and C231, showed evidence that the major part of
the variant in vitro exoproteome is contained in the
core ISPPE. A simultaneous curation of the in silico pre-
dicted core secretome and surfaceome within the five
C. pseudotuberculosis strains also contributed to homo-
genize the genome annotations and it was possible to fix
the most probable putative methionine proteins. More-
over, putative miss assembled genes, formerly classified
as pseudogenes by in silico analyses, were also revised.
The efforts to create a C. pseudotuberculosis ISSPE cata-
logue proved to be necessary and computationally viable
to ensure a uniform set of putative vaccine candidates
free of annotation errors.
Methods
Genomes
The analyzed C. pseudotuberculosis genomes were
obtained from the GenBank according to the following
accession numbers: EMBL: CP001809 (strain 1002),
EMBL: CP001809 (strain C231), EMBL: CP002251 (strain
I19), EMBL: CP002924 (strain PAT10) and EMBL:
NC_014329 (strain FRC41).
Prediction schema
Predicted genes from all five C. pseudotuberculosis strain
genomes were exported as amino acid fasta files using the
Artemis software. These fasta files were passed as para-
meters to SurfG+ 1.0 (Figure 1), and lists of genes pre-
dicted as CYT, SEC, PSE and MEM were created by this
software. Genes formerly predicted as CYT by SurfG+
were then submitted to the TapP 1.0 predictor; when a
Tat motif was found, the putative protein was automati-
cally classified as SEC, otherwise, another prediction
round would took place using two other non-classic secre-
tion predictors, SecretomeP 2.0 and NclassG+ 1.0. With a
positive prediction from both software and a prediction
score greater than or equal to 0.90, the genes were auto-
matically classified as SEC. The SEC and PSE data sets
were finally submitted to a reciprocal blastp processing
and posterior filtering, giving rise to the fivefold categories
according to folds occurring in each strain: 5x, 4x, 3x, 2x
and 1x. The results were then manually curated using the
ACT software and strain 1002, the first to be sequenced
and annotated. The strain 1002 was disposed, in ACT soft-
ware, in the middle of two pairs of the other two genome
strains, facilitating to exhibit differences among all of
them.
SurfG+ 1.0
Sub-cellular localization prediction of C. pseudotuberculo-
sis putative proteins was made by in silico analysis using
the SurfG+ 1.0 software [6]. SurfG+ is a pipeline for pro-
tein sub-cellular prediction that incorporates common
software, such as SignalP, LipoP and TMHMM to search
for motifs. It also creates novel HMMSEARCH profiles to
predict cell wall retention signals. SurfG+ starts searching,
in the following order for: retention signals, lipoproteins,
SEC pathway export motifs and transmembrane motifs. If
none of these motifs are found in a protein sequence, it is
then characterized as CYT. A novel possible characteriza-
tion introduced by SurfG+ is its ability to better distin-
guish between MEM and PSE, by informing an expected
cell wall thickness in amino acids. Using the literature or
an electronic microscopy it is possible to estimate a rea-
sonable cell wall thickness value for prokaryotic organ-
isms. By means of this last option, C. pseudotuberculosis
genes were classified into four different sub-cellular loca-
tions: CYT, MEM, PSE, or SEC.
TatP 1.0 Server
Twin-arginine signal peptide motifs were predicted
using the on line server hosted by http://www.cbs.dtu.
dk/services/TatP/[20]. Only putative proteins formerly
classified as CYT by SurfG+ were submitted to the TatP
analyses. There were no intersections between SignalP
and TatP predictions.
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SecretomeP 2.0 and NClassG+ 1.0
Non-classical secreted putative proteins were predicted
using the online server hosted by http://www.cbs.dtu.dk/
services/SecretomeP/[21]. NClassG+ [22], a second non-
classical secreted protein predictor, was also used; how-
ever, the predictions were directly performed contacting
the software authors. This double check prediction
ensured greater accuracy. Only those genes formerly clas-
sified as CYT by SurfG+ and without the twin-arginine
signal peptide motifs were submitted to a non-classical
secreted analysis. Despite the significant scores of Secreto-
meP and Nclass+, ranging between 0.5 and 1.0, only those
genes with a score greater than or equal to 0.9 were
selected, in order to ensure a minimal false positive in
future wet lab experiments, the focus of our research
group.
Pan genome
To predict the C. pseudotuberculosis pan genome, recipro-
cal blastp results were used. All the putative proteins pre-
dicted as SEC were put apart in a single amino acid fasta
file to make a reciprocal blast. A similar file was also cre-
ated for the proteins predicted as PSE. To avoid homolo-
gous mismatches, the blastp results obtained using the
PAM70 substitution matrix and the 10-6 e-value were
manually filtered. In this regard, the first step was to estab-
lish the alignment size and identity percentages of cut-offs,
being 89.58 and 50.00%, respectively, for SEC putative pro-
teins, whereas for PSE putative proteins, these cut-offs
were 88.16 and 48.80%, respectively. Identity percentages
closer to 50% are explained by frame shifts not annotated
until this work. All the putative proteins from the five
strains (query) with alignment size and identity percen-
tages higher than these cut-offs had no more than one
group of blast hits (subject) against the others strains.
Moreover, within each of these blast hits groups, there
was a blast hit from the query protein against it self as
subject. The results were manually curated using the ACT
software, from the Artemis package [24], using the strain
1002 as reference strain for the other two strains. This
ACT view was composed by strains C231-1002-I19 and
FRC41-1002-I19. Each putative protein predicted as SEC
and PSE was compared against their other four homolo-
gues for correct initial methionine, frame shifts and finally
annotating the correct sub-cellular location.
Revised in vitro exoproteome results
In lists 1 and 2 of the annex are both gene locus present
in the C. pseudotuberculosis ISPPE, together with the
quantity of homologous genes present in the all five gen-
omes. These results were inserted in a relational data-
base, denominated C. pseudotuberculosis Data Base
(CpDB) [36], in a specific table called ‘exopred’. The list
of the in vitro exoproteome proteins was also inserted to
the CpDB into a table called ‘exo’ that discriminates the
identification of each protein regarding GenBank (protein
id), as well as in which strains it is found. To make a rela-
tionship between the ‘exopred’ and ‘exo’ tables, a third
table of the CpDB, called ‘gene’, which contains all the
functional annotation of the genomes of C. pseudotuber-
culosis, was created. The CpDB is the repository of the
pan genome of C. pseudotuberculosis, harbouring the
genomes since their initial genomic prediction, deposited
in the GenBank, as well as the annotation corrections for
future deposits. For this last purpose, the CpDB stores
the identification of each protein according to the Gen-
Bank. In this way, it is possible to make a link between
the three tables in the form of a clause of JOIN of the
SQL: “... WHERE gene.locus_tag = exopred.locus_tag
AND gene.protein_id = exo.protein_id AND exopred.pan-
genome_coverage = ‘5x’ ...”. This clause returns the regis-
tries of the CpDB whose locus_tag in the gene table is
equal to the locus_tag of the explored table, being this
same gene in the protein_id field in the exo table with
prediction of belonging to all five genomes. Other condi-
tions can also be included, such as for example, restrain-
ing the results to specific genes of a C. pseudotuberculosis
strain or simultaneously present in the exoproteome of
specific strains.
Additional material
Additional file 1: C. pseudotuberculosis genomes. The five
C. pseudotuberculosis genomes here checked, as EMBL files.
Additional file 2: Predicted C. pseudotuberculosis pan secretome. List
of the 150 genes for 750 locus_tags from the five C. pseudotuberculosis
strains.
Additional file 3: Predicted C. pseudotuberculosis pan surfaceome.
List of the 227 genes for 1135 locus_tags from the five
C. pseudotuberculosis strains.
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